Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


1 Acta Haematol
2 Am J Clin Pathol
1 Am J Hematol
3 Ann Hematol
1 Biochem Biophys Res Commun
3 Blood
2 BMC Cancer
2 Cancer
1 Cancer Lett
1 Cancer Res
1 Eur J Haematol
1 Int J Hematol
1 J Pediatr Hematol Oncol
3 Leuk Lymphoma
4 Leuk Res
3 Leukemia
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Haematol

    Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
    Acta Haematol. 2019 Jul 17:1-2. doi: 10.1159/000501330.
    PubMed     Text format    

    Am J Clin Pathol

  2. GILLES SR, Yohe SL, Linden MA, Dolan M, et al
    CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
    Am J Clin Pathol. 2019 Jul 15. pii: 5532262. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. MILLER KP, Venkataraman G, Gocke CD, Batista DA, et al
    Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide.
    Am J Clin Pathol. 2019 Jul 15. pii: 5532258. doi: 10.1093.
    PubMed     Text format     Abstract available

    Am J Hematol

  4. JIANG H, Li C, Yin P, Guo T, et al
    Anti-CD19 CAR-T Therapy Bridging to Allo-HSCT for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: An Open-Label Pragmatic Clinical Trial.
    Am J Hematol. 2019 Jul 18. doi: 10.1002/ajh.25582.
    PubMed     Text format     Abstract available

    Ann Hematol

  5. JIANG H, Liu L, Guo T, Wu Y, et al
    Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy.
    Ann Hematol. 2019;98:1721-1732.
    PubMed     Text format     Abstract available

  6. YAMASAKI S, Nitta H, Kondo E, Uchida N, et al
    Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
    Ann Hematol. 2019 Jul 20. pii: 10.1007/s00277-019-03759.
    PubMed     Text format     Abstract available

  7. STAMOULI M, Gkirkas K, Antoniades A, Kaklamanis L, et al
    Isolated extramedullary leukemic involvement of the heart presenting as fulminant heart failure.
    Ann Hematol. 2019;98:1775-1776.
    PubMed     Text format    

    Biochem Biophys Res Commun

  8. ZHU HY, Huang ZX, Chen GQ, Sheng F, et al
    Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy.
    Biochem Biophys Res Commun. 2019 Jul 10. pii: S0006-291X(19)31206.
    PubMed     Text format     Abstract available


  9. FERGUSON D, Kovach AE
    Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency.
    Blood. 2018;132:673.
    PubMed     Text format    

  10. VOGIATZI F, Winterberg D, Lenk L, Buchmann S, et al
    Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
    Blood. 2019 Jul 16. pii: blood.2019000904. doi: 10.1182/blood.2019000904.
    PubMed     Text format    

  11. GOCHO Y, Yang JJ
    Genetic Defects in Hematopoietic Transcription Factors and Predisposition to Acute Lymphoblastic Leukemia.
    Blood. 2019 Jul 16. pii: blood.2018852400. doi: 10.1182/blood.2018852400.
    PubMed     Text format     Abstract available

    BMC Cancer

  12. NUNEZ-ENRIQUEZ JC, Gil-Hernandez AE, Jimenez-Hernandez E, Fajardo-Gutierrez A, et al
    Overweight and obesity as predictors of early mortality in Mexican children with acute lymphoblastic leukemia: a multicenter cohort study.
    BMC Cancer. 2019;19:708.
    PubMed     Text format     Abstract available

  13. BAWAZIR A, Al-Zamel N, Amen A, Akiel MA, et al
    The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999-2013).
    BMC Cancer. 2019;19:703.
    PubMed     Text format     Abstract available


  14. BOULET-CRAIG A, Robaey P, Barlaam F, Laniel J, et al
    Visual short-term memory activation patterns in adult survivors of childhood acute lymphoblastic leukemia.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32374.
    PubMed     Text format     Abstract available

  15. SASAKI K, Kantarjian HM, Kadia T, Patel K, et al
    Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32387.
    PubMed     Text format     Abstract available

    Cancer Lett

  16. HUANG S, Pan J, Jin J, Li C, et al
    Abivertinib, a novel BTK inhibitor: anti-leukemia effects and synergistic efficacy with Homoharringtonine in acute myeloid leukemia.
    Cancer Lett. 2019 Jul 13. pii: S0304-3835(19)30404.
    PubMed     Text format     Abstract available

    Cancer Res

  17. BURSLEM GM, Schultz AR, Bondeson DP, Eide CA, et al
    Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-mediated Targeted Protein Degradation.
    Cancer Res. 2019 Jul 16. pii: 0008-5472.CAN-19-1236.
    PubMed     Text format     Abstract available

    Eur J Haematol

  18. LAUSEKER M, Gerlach R, Worseg W, Haferlach T, et al
    Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: results from a population-based study.
    Eur J Haematol. 2019 Jul 15. doi: 10.1111/ejh.13293.
    PubMed     Text format     Abstract available

    Int J Hematol

  19. LI C, Cai X, Chen X, Liang Y, et al
    Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
    Int J Hematol. 2019 Jul 18. pii: 10.1007/s12185-019-02703.
    PubMed     Text format     Abstract available

    J Pediatr Hematol Oncol

  20. ELDEM I, Al-Rahawan MM, Levent F
    How to Treat Cytomegalovirus-induced Hemophagocytic Lymphohistiocytosis in a Child With Leukemia.
    J Pediatr Hematol Oncol. 2019 Jul 10. doi: 10.1097/MPH.0000000000001547.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  21. ALFAYEZ M, Burger JA, Kadia T, Xu TH, et al
    Plesiomonas shigelloides gastroenteritis in a patient with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2019 Jul 15:1-2. doi: 10.1080/10428194.2019.1639171.
    PubMed     Text format    

  22. CHEN Z, Mai W, Li Z, Zhang H, et al
    The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
    Leuk Lymphoma. 2019 Jul 15:1-12. doi: 10.1080/10428194.2019.1639164.
    PubMed     Text format     Abstract available

  23. DHAKAL P, Kaur J, Gundabolu K, Raj Bhatt V, et al
    Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?
    Leuk Lymphoma. 2019 Jul 18:1-11. doi: 10.1080/10428194.2019.1641802.
    PubMed     Text format     Abstract available

    Leuk Res

  24. MARTINEZ-CUADRON D, Gil C, Serrano J, Rodriguez G, et al
    A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
    Leuk Res. 2019;76:1-10.
    PubMed     Text format     Abstract available

  25. HEIBLIG M, Sujobert P, Hayette S, Balsat M, et al
    Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience.
    Leuk Res. 2019;76:29-32.
    PubMed     Text format    

  26. HUANG SJ, Chan J, Bruyere H, Allan LL, et al
    Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Leuk Res. 2019;84:106193.
    PubMed     Text format     Abstract available

  27. HUTMACHER C, Volta L, Rinaldi F, Murer P, et al
    Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia.
    Leuk Res. 2019;84:106178.
    PubMed     Text format     Abstract available


  28. HUMBERT O, Laszlo GS, Sichel S, Ironside C, et al
    Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2.
    Leukemia. 2019;33:762-808.
    PubMed     Text format    

  29. BENAJIBA L, Alexe G, Su A, Raffoux E, et al
    Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML.
    Leukemia. 2019;33:800-804.
    PubMed     Text format    

  30. CAO J, Cheng H, Shi M, Wang G, et al
    Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia.
    Leukemia. 2019 Jul 15. pii: 10.1038/s41375-019-0516.
    PubMed     Text format    

    PLoS One

  31. MEYER LK, Delgado-Martin C, Maude SL, Shannon KM, et al
    CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    PLoS One. 2019;14:e0220026.
    PubMed     Text format     Abstract available

  32. TROJANI A, Pungolino E, Dal Molin A, Lodola M, et al
    Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
    PLoS One. 2019;14:e0218444.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.